Updates are available New edition dated 2024-10-14

Click to view New edition: https://doi.org/10.29328/journal.jcn.1001141

Serum Levels of the C-terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients with Hemodialysis Undergoing Treatment with a Proline Hydroxylase Domain (PHD) Inhibitor

Crossref DOI link: https://doi.org/10.29328/journal.jcn.1001141

Published Online: 2024-10-14

Published Print: 2024-10-14

Update policy: https://doi.org/10.29328/crossmark-policy

About CrossMark